Visit our CLL Information and Resource CentreA guide for patients looking for answers to their CLL questions on the Internet. |
A new Canadian website is making it easier for cancer patients to explore clinical trial options. Search for trials across Canada using simple keywords and filters or get help navigating the site through the Canadian Cancer Society’s Cancer Information Helpline.
In late 2025, the American Society of Hematology (ASH) conference highlighted many important updates for people living with Chronic Lymphocytic Leukemia (CLL), including emerging treatment approaches, long-term follow-up on existing therapies.
Calling all patients and care partners to share their experiences to improve patient outcomes. The 2026 Global Patient Survey on Lymphoma & CLL (GPS) is the only opportunity for the worldwide lymphoma and CLL community of patients and care partners to share insights…
Pirtobrutinib (brand name Jaypirca) has been approved by Health Canada and is available for use as monotherapy for the treatment of adult patients in Canada with CLL/SLL who have received at least two prior lines of therapy…
